Immunovia announced that its U.S. subsidiary, Immunovia Inc., has appointed a new National Sales Director. Jon Hager starts in his position and has an extensive track record as a top-performing sales leader at companies like Ethos Labs, Myriad Genetics and Pfizer. He has earned multiple sales awards and promotions for his results and brings a wealth of experience growing new products, including at Myriad Genetics where he was a core member of the team that launched hereditary cancer testing to gynecologists.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 SEK | +0.25% |
|
-8.52% | -9.14% |
05-21 | Immunovia Seeks SEK70 Million from Proposed Rights Offering | MT |
04-29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 |
1st Jan change | Capi. | |
---|---|---|
-9.14% | 6.88M | |
-34.27% | 14.75B | |
-54.93% | 2.22B | |
+15.49% | 1.82B | |
-14.07% | 1.43B | |
+21.99% | 1.23B | |
+1.25% | 784M | |
-35.50% | 741M | |
-36.65% | 723M | |
-28.15% | 602M |
- Stock Market
- Equities
- IMMNOV Stock
- News Immunovia AB
- Immunovia Inc. Appoints Jon Hager as New National Sales Director